Esterase-activated fluorescent prodrug for targeted early diagnosis and treatment of hepatic fibrosis
Crossref DOI link: https://doi.org/10.1007/s11426-025-2731-6
Published Online: 2025-09-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ai, Jiahong
Li, Xingwei
Zhang, Yurong
Huo, Fangjun
Yin, Caixia
Text and Data Mining valid from 2025-09-04
Version of Record valid from 2025-09-04
Article History
Received: 17 March 2025
Accepted: 25 April 2025
First Online: 4 September 2025
Ethics
: Conflict of interest The authors declare no conflict of interest.